Buy VistaGen Therapeutics Stock | VTGN Stock Price & Latest News | Public
VTGN

VistaGen Therapeutics

$0.00 (0.00%)Today
    Small Market Cap

    About VTGN

    VistaGen Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of new generation medicines to treat diseases and disorders of the central nervous system. Its portfolio focuses on three clinical-stage product; neuropathic pain...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.02
    -0.05
    -0.07
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.06

    Actual EPS
    Q1 2021

    Stats

    Market Cap$44,75M
    Volume9,59k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$1.06
    1 Year Low$0.30
    Open$0.78
    High$0.78
    Low$0.75

    Buy any stock with any amount of money.

    Download the App
    Download the app